Yasuhiro Hiyoshi
Sagamihara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.
Journal: Thoracic cancer
Published: February 12, 2021
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Journal: Thoracic cancer
Published: November 12, 2019
Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Journal: Thoracic cancer
Published: July 16, 2019
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
Journal: Cancer management and research
Published: February 28, 2019
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study.
Journal: Thoracic cancer
Published: January 04, 2019
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
Journal: Cancer management and research
Published: December 13, 2018
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non-small cell lung cancer.
Journal: Thoracic cancer
Published: November 06, 2018
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
Journal: Clinical lung cancer
Published: January 24, 2018
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.
Journal: Investigational new drugs
Published: May 23, 2017
Last Updated: 09/26/2026